Cargando…
3′UTR shortening of profibrotic genes and reversibility of fibrosis in patients with end‐stage right ventricular failure
Autores principales: | Neupane, Rahul, Cieslik, Katarzyna A., Youker, Keith, Palaniyandi, Suresh Selvaraj, Guha, Ashrith, Thandavarayan, Rajarajan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460478/ https://www.ncbi.nlm.nih.gov/pubmed/36082691 http://dx.doi.org/10.1002/ctm2.1017 |
Ejemplares similares
-
Aldehyde Dehydrogenase 2 Activator Augments the Beneficial Effects of Empagliflozin in Mice with Diabetes-Associated HFpEF
por: Pan, Guodong, et al.
Publicado: (2022) -
SARS–CoV-2 Mediated Hyperferritinemia and Cardiac Arrest: Preliminary Insights
por: VasanthiDharmalingam, Prakash, et al.
Publicado: (2021) -
ALDH2 Inhibition Potentiates High Glucose Stress-Induced Injury in Cultured Cardiomyocytes
por: Pan, Guodong, et al.
Publicado: (2016) -
Small molecule disruption of G protein βγ subunit signaling reprograms human macrophage phenotype and prevents autoimmune myocarditis in rats
por: Karuppagounder, Vengadeshprabhu, et al.
Publicado: (2018) -
An In Vitro Platform to Study Reversible Endothelial-to-Mesenchymal Transition
por: Krishnamoorthi, Muthu Kumar, et al.
Publicado: (2022)